0000899243-18-025393.txt : 20180926
0000899243-18-025393.hdr.sgml : 20180926
20180926214038
ACCESSION NUMBER: 0000899243-18-025393
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180924
FILED AS OF DATE: 20180926
DATE AS OF CHANGE: 20180926
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Castelein Caley
CENTRAL INDEX KEY: 0001355758
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38560
FILM NUMBER: 181089327
MAIL ADDRESS:
STREET 1: THOM. WEISEL HEALTHCARE VENTURES
STREET 2: ONE MONTGOMERY STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aerpio Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001422142
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 611547850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9987 CARVER ROAD
CITY: CINCINNATI
STATE: OH
ZIP: 45242
BUSINESS PHONE: (513) 985-1920
MAIL ADDRESS:
STREET 1: 9987 CARVER ROAD
CITY: CINCINNATI
STATE: OH
ZIP: 45242
FORMER COMPANY:
FORMER CONFORMED NAME: ZETA ACQUISITION CORP II
DATE OF NAME CHANGE: 20071227
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-09-24
0
0001422142
Aerpio Pharmaceuticals, Inc.
ARPO
0001355758
Castelein Caley
ONE EMBARCADERO, SUITE 3700
SAN FRANCISCO
CA
94111
1
0
0
0
Common Stock
2018-09-24
4
J
0
268987
0.00
A
279907
D
Common Stock
2018-09-24
4
D
0
1603526
0.00
D
0
I
See Footnote
These shares were received pursuant to a distribution made by Kearny Venture Associates III, LLC in connection with the entity's liquidation.
Consists of (i) 1,571,475 shares of Common Stock owned directly by Kearny Venture Partners, L.P., or KVP, and (ii) 32,051 shares of Common Stock owned directly by Kearny Venture Partners Entrepreneurs Fund, L.P., or KVPE. The general partner of both KVP and KVPE is Kearny Venture Associates, L.L.C., or KVA. KVA has the sole voting and investment control over the shares owned by KVP and KVPE, and the Managing Members of KVA share in the voting and investment control over such shares controlled by KVA. The Managing Members of KVA are Caley Castelein, Richard Spalding and James Shapiro. None of the Managing Members of KVA has individual voting or investment power with respect to such shares and each disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein. These shares were distributed to third parties pursuant to a distribution made by the entities in connection with their liquidation.
/s/ Caley Castelein
2018-09-25